BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kane Biotech Inc. 

6-1200 Waverley Street

Winnipeg  Manitoba  R3T 0P4  Canada
Phone: 204-487-7412 Fax: 204-488-9823


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Research





 Company News
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014 9:04:23 AM
Kane Biotech Inc. (KNE) Receives Approval from Health Canada for Hard Surface Disinfectant 10/12/2011 6:50:13 AM
Kane Biotech Inc. (KNE) Release: DispersinB(R) Wound Spray Passes Final Biocompatibility Sub-Chronic Toxicity Test 1/26/2011 10:31:47 AM
Kane Biotech Inc. (KNE) Announces Grant of Options 1/19/2011 10:12:45 AM
Kane Biotech Inc. (KNE) Retains Pure Advertising & Marketing for Investor Relations 1/13/2011 9:54:25 AM
Kane Biotech Inc. (KNE) Receives $100,000 in Financial Assistance from the Government of Manitoba 12/15/2010 9:43:26 AM
Kane Biotech Inc. (KNE) Issued US Patent for DispersinB(R) Wound Care Technology 11/16/2010 11:12:28 AM
Kane Biotech Inc. (KNE)'s DispersinB(R) Topical Wound Spray Passes Critical Sensitization Test 11/8/2010 9:54:00 AM
Kane Biotech Inc. (KNE) Appoints Board Advisor and Announces Private Placement Offering 11/2/2010 9:43:13 AM
Kane Biotech Inc. (KNE)'s DispersinB(R) Wound Spray Passes First Set of Biocompatibility Tests 10/4/2010 9:38:01 AM
12345678